These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9269994)
21. BRCA1 expression during prenatal development of the human mammary gland. Magdinier F; Dalla Venezia N; Lenoir GM; Frappart L; Dante R Oncogene; 1999 Jul; 18(27):4039-43. PubMed ID: 10435628 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679 [TBL] [Abstract][Full Text] [Related]
23. BRCA1 promotes induction of ssDNA by ionizing radiation. Schlegel BP; Jodelka FM; Nunez R Cancer Res; 2006 May; 66(10):5181-9. PubMed ID: 16707442 [TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476 [TBL] [Abstract][Full Text] [Related]
25. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair--perhaps through transcription. Somasundaram K J Cell Biochem; 2003 Apr; 88(6):1084-91. PubMed ID: 12647291 [TBL] [Abstract][Full Text] [Related]
26. DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting. Ree AH; Stokke T; Bratland A; Patzke S; Nome RV; Folkvord S; Meza-Zepeda LA; Flatmark K; Fodstad O; Andersson Y Anticancer Res; 2006; 26(3A):1909-16. PubMed ID: 16827124 [TBL] [Abstract][Full Text] [Related]
27. BRCA1 in non-inherited breast carcinomas (Review). Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Oncol Rep; 2002; 9(6):1329-33. PubMed ID: 12375043 [TBL] [Abstract][Full Text] [Related]
28. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506 [TBL] [Abstract][Full Text] [Related]
29. Dysfunctional BRCA1 is only indirectly linked to multiple centrosomes. Hut HM; Rembacz KP; van Waarde MA; Lemstra W; van Cappellen WA; Kampinga HH; Sibon OC Oncogene; 2005 Nov; 24(51):7619-23. PubMed ID: 16205648 [TBL] [Abstract][Full Text] [Related]
30. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Li H; Weinstein IB Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886 [TBL] [Abstract][Full Text] [Related]
31. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Liberto M; Cobrinik D; Minden A Oncogene; 2002 Feb; 21(10):1590-9. PubMed ID: 11896588 [TBL] [Abstract][Full Text] [Related]
32. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line. Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754 [TBL] [Abstract][Full Text] [Related]
33. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184 [TBL] [Abstract][Full Text] [Related]
34. Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells. Ogryzko VV; Brinkmann E; Howard BH; Pastan I; Brinkmann U Biochemistry; 1997 Aug; 36(31):9493-500. PubMed ID: 9235994 [TBL] [Abstract][Full Text] [Related]
35. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Xu X; Weaver Z; Linke SP; Li C; Gotay J; Wang XW; Harris CC; Ried T; Deng CX Mol Cell; 1999 Mar; 3(3):389-95. PubMed ID: 10198641 [TBL] [Abstract][Full Text] [Related]
36. Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Tominaga Y; Wang A; Wang RH; Wang X; Cao L; Deng CX Cell Death Differ; 2007 Mar; 14(3):472-9. PubMed ID: 17024228 [TBL] [Abstract][Full Text] [Related]
38. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Deng CX Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699 [TBL] [Abstract][Full Text] [Related]
39. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Arlt MF; Xu B; Durkin SG; Casper AM; Kastan MB; Glover TW Mol Cell Biol; 2004 Aug; 24(15):6701-9. PubMed ID: 15254237 [TBL] [Abstract][Full Text] [Related]
40. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. Okada S; Ouchi T J Biol Chem; 2003 Jan; 278(3):2015-20. PubMed ID: 12427729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]